In this free webinar, learn about advancements in cell line development and glycoengineering. Attendees will gain insights into how precise glycan modulation boosts antibody-dependent cell-mediated ...

antibody-dependent cellular phagocytosis (ADCP), antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent complement deposition (ADCD), and CDC. All three anti-CD20 mAbs, RTX ...

and on the other side binds to NK cells to stimulate a phenomenon known as antibody-dependent cellular cytotoxicity (ADCC), which prompts immune cells to kill cancer cells. Experiments on NSCLC ...

and on the other side binds to NK cells to stimulate a phenomenon known as antibody-dependent cellular cytotoxicity (ADCC), which prompts immune cells to kill cancer cells. Experiments on NSCLC ...

People with vasculitis may need at least three or four vaccinations for COVID-19 before they start to show an immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ...

Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...

and enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) activity. Merus is a clinical-stage oncology company developing innovative ...

or bring a T cell adjacent to the tumor (e.g., bispecific mAb). ADCC: Antibody-dependent cellular cytotoxicity; mAb: Monoclonal antibody.

Our team’s strong focus and execution over the last twelve months lay the groundwork for a potential breakthrough year for iTeos in 2025. As we advance multiple trials evaluating belrestotug + ...

Open label study in forty AML and MDS patientsStudy financed by the US Department of DefenseCantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today announced that the first subject ...

To improve antibody binding, the researchers generated ... specific BNAbs target autologous HIV-1–infected CD4+ T cells by ADCC, The Journal of Immunology (2025). DOI: 10.1093/jimmun/vkae028 ...

Figure 1: Antibody design to improve homogeneity and ... and associated with enhanced or silenced effector functions (ADCC or complement-dependent cytotoxicity) are being investigated in clinical ...